Tulixon (ceftriaxone, sulbactam) powder for solution for injections vial №1

$18.80

Manufacturer: India

Purpose: Combats bacterial infections by inhibiting cell wall synthesis.

SKU: MED61821 Categories: ,

Description

Tulixon (ceftriaxone, sulbactam) powder for solution for injections vial №1

Ingredients

Active ingredients: Ceftriaxone and sulbactam.

Dosage

Dosage: The dosage of Tulixon depends on the severity of the infection and should be determined by a healthcare professional.

Indications

Indications: Tulixon is indicated for the treatment of various bacterial infections such as respiratory tract infections, skin and soft tissue infections, urinary tract infections, and septicemia.

Contraindications

Contraindications: Do not use Tulixon if you are allergic to ceftriaxone, sulbactam, or any other ingredients in the product.

Directions

Directions: Tulixon is administered by intravenous or intramuscular injection as directed by a healthcare provider.

Scientific Evidence

Scientific Evidence: Studies have shown the efficacy of ceftriaxone and sulbactam in treating various bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the effectiveness of this combination in combating multidrug-resistant bacteria.

Additional Information

Pharmacological Effects: Ceftriaxone inhibits bacterial cell wall synthesis, while sulbactam enhances ceftriaxone’s activity against beta-lactamase-producing bacteria. This combination provides a broad spectrum of antibacterial coverage.

Clinical Trials: Clinical trials have shown Tulixon to be effective in treating severe infections and have demonstrated its safety profile. A study published in the International Journal of Infectious Diseases highlighted the positive outcomes of Tulixon in complicated urinary tract infections.

Overall, Tulixon (ceftriaxone, sulbactam) powder for solution for injections is a potent antibiotic combination with proven efficacy in treating a wide range of bacterial infections. Its pharmacological actions and clinical trial data support its use as a reliable option in the management of serious infections.